Walmark Meditech Private Limited, a active private limited company, was established on 04 November 2010 in Nagpur, Maharashtra, India. Engaging in medicinal chemical & botanical products within the manufacturing sector, it holds CIN: U51101MH2010PTC209825. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹10.55 Cr and a paid-up capital of ₹5.88 Cr.
It upholds a compliant status. Employing 24 professional, Its leadership includes Vilas Raghunath Page (Director), Saroj Vilas Page (Director), Rahul Vilas Page (Managing Director). Past directors included Kushal Sanjay Kholapurkar. It holds ₹54.73 Cr open charges and ₹19.51 Cr settled loans. Its latest AGM occurred on 30 November 2021, with the balance sheet filed on 31 March 2021. It is based at D-34, Midc Industrial Area Butiboti, Nagpur, Maharashtra, 441122.
U51101MH2010PTC209825
209825
04 November 2010
₹10.55 Cr
₹5.88 Cr
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Walmark Meditech Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Vilas Raghunath Page | Director | 04 Nov 2010 | Current |
| Saroj Vilas Page | Director | 04 Nov 2010 | Current |
| Rahul Vilas Page | Managing Director | 04 Nov 2010 | Current |
| Kushal Sanjay Kholapurkar | Director | 01 Mar 2014 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 30 Sep 2014 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Walmark Meditech Private Limited, for the financial year ended 2021, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
In 2021, Walmark Meditech had a promoter holding of 85.00% and a public holding of 15.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹547,257,000.00
₹195,053,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 28 Sep 2020 | Abhyudaya Co-Operative Bank Limited | ₹6.36 M | Open |
| 17 Jul 2019 | Abhyudaya Co-Operative Bank Limited | ₹18.00 Cr | Open |
| 29 Jun 2019 | Abhyudaya Co-Operative Bank Limited | ₹12.00 Cr | Open |
| 29 Jun 2019 | Abhyudaya Co-Operative Bank Limited | ₹6.00 Cr | Open |
| 29 Jun 2019 | Abhyudaya Co-Operative Bank Limited | ₹6.00 Cr | Open |
Explore comprehensive loan charge details -
Walmark Meditech has a workforce of 24 employees as of Nov 21, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Walmark Meditech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Walmark Meditech's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Walmark Meditech Private Limited last Annual general meeting of members was held on 30 Nov 2021 as per latest MCA records. was documented.
Progress on Walmark Meditech Private Limited has filed its annual Financial statements for the year ended 31 Mar 2021 with Roc Mumbai. was documented.
Progress on A charge with Abhyudaya Co-Operative Bank Limited amounted to Rs. 0.64 Cr with Charge ID 100380645 was registered on 28 Sep 2020. was documented.
A charge with Abhyudaya Co-Operative Bank Limited amounted to Rs. 18.00 Cr with Charge ID 100282926 was registered on 17 Jul 2019. was recorded as a recent event.
The activity A charge registered on 31 Mar 2012 via Charge ID 10350904 with Bank Of Baroda was fully satisfied on 09 Jul 2019. was completed.
Progress on A charge with Abhyudaya Co-Operative Bank Limited amounted to Rs. 12.00 Cr with Charge ID 100275645 was registered on 29 Jun 2019. was documented.
The CIN of Walmark Meditech Private Limited is U51101MH2010PTC209825.
Walmark Meditech Private Limited is headquartered at D-34, Midc Industrial Area Butiboti, Nagpur, Maharashtra, 441122.
Walmark Meditech Private Limited was incorporated on 04 November 2010.
The current directors of Walmark Meditech Private Limited are
The primary industry of Walmark Meditech Private Limited is Manufacturing.
Walmark Meditech Private Limited is unlisted.
The authorized capital of Walmark Meditech Private Limited is ₹10.55 Cr, and the paid-up capital is ₹5.88 Cr.
The compliance status of Walmark Meditech Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX